Lykos Therapeutics catalyzes healing and well-being through psychedelic drug development, therapist training programs.
Lykos Therapeutics has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in May 2025.
Lykos Therapeutics's investors include True Ventures, Unlikely Collaborators, Mystic Ventures, KittyHawk, Satori Capital.
Lykos Therapeutics is headquartered in San Jose, United States.
Lykos Therapeutics catalyzes healing and well-being through psychedelic drug development, therapist training programs.
Lykos Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lykos Therapeutics — Funding & Investors." VCBacked, May 30, 2025, https://www.vcbacked.co/company/lykos-therapeutics. Accessed July 21, 2026.
VCBacked. (2025). Lykos Therapeutics — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/lykos-therapeutics
{{cite web |title=Lykos Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lykos-therapeutics |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated